SIPLIZUMAB
UNII KUW1QG1ZM3

Substance Identification & Data

This profile provides standardized clinical and technical data for Siplizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KUW1QG1ZM3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 288392-69-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

KUW1QG1ZM3

CAS Registry Number

288392-69-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SIPLIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C38685

National Cancer Institute reference terminology for clinical and research data.

INN ID

8251

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NN-38

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Siplizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SIPLIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD2 (ANTIGEN)) (HUMAN-RAT MONOCLONAL MEDI-507 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-RAT MONOCLONAL MEDI-507 LIGHT CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD2 (ANTIGEN)) (HUMAN-RAT MONOCLONAL MEDI-507 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-RAT MONOCLONAL MEDI-507 LIGHT CHAIN, DIMER

SIPLIZUMAB [INN]

SIPLIZUMAB [USAN]

SIPLIZUMAB [WHO-DD]